BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 6, 2026
See today's BioWorld Asia
Home
» Does China have what it takes to supply the Global Fund?
To read the full story,
subscribe
or
sign in
.
Does China have what it takes to supply the Global Fund?
April 9, 2014
By
Shannon Ellis
HONG KONG – The Global Fund for AIDS, Tuberculosis and Malaria based in Geneva, was in Shanghai last week initiating talks on how to source directly the antiretroviral (ARV) drugs it distributes to patients in need around the world.
BioWorld Asia